NPI registry status
Active
2026 NPPES data Endocrinology, Diabetes & Metabolism Physician NPI 1447231147 M.D.
Verify on CMS → Seema Ahluwalia, M.D.
Endocrinology, Diabetes & Metabolism Physician in Chandler, Arizona.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 8,078 in Endocrinology, Diabetes & Metabolism Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
8K
Medicare Part D claims · 1K beneficiaries · Endocrinology, Diabetes & Metabolism Physician avg: 3K
Generic prescribing
39%
generic claims · 51% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
75/100
CMS neutral threshold · no category scores published
Industry payments
$3.3K
143 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Seema Ahluwalia, M.D. carries the neutral CMS MIPS final score of 75/100, assigned where no category was scored - and filed 8,215 Medicare Part D claims in 2024.
- 75/100
- CMS neutral score · not measured
- 8K
- Part D claims, 2024
- 39%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Seema Ahluwalia, M.D.
Federal records show an active NPI with Medicare Part D prescribing activity — verifiable registry data, not a proprietary rating.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1447231147), first enumerated 11/09/2005.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 8,215 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
CMS quality reporting (MIPS)
CMS assigned a neutral MIPS final score of 75/100 where no performance category was scored — not a measured quality rank.
Source: CMS Quality Payment Program
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- Reported
Industry payment transparency
$3.3K in reported industry payments (143 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1447231147 · Endocrinology, Diabetes & Metabolism Physician
NPI-10 · ENUM-LEGACY · TAX-MID · MIPS-NEUTRAL · RX-MID · BOOK-THIN · PHOTO-ENUM
- NPI-10 1447231147
- ENUM-LEGACY 2005
- TAX-MID 8K Endocrinology, Diabetes
- MIPS-NEUTRAL 75/100
- RX-MID 8,215
- BOOK-THIN 120 in Arizona
- PHOTO-ENUM Yolanta Kruszynska · 2005
Seema Ahluwalia, M.D.'s Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2024, across all CMS prescribers nationally
8,215 ≥ 97th percentile 97% of 1,416,883 prescribers are in lower value bands
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.
Source CMS Medicare Part D Prescriber Public Use File · 2024
✓
Board certification likely (heuristic, not verified)
Seema Ahluwalia, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Seema Ahluwalia, M.D.?
CMS neutral score, not measuredPrimary specialty
Endocrinology, Diabetes & Metabolism Physician
Medicare Part D claims
8,215 200% vs specialty avg
MIPS final score
75/100
Specialty distribution in Arizona
How Endocrinology, Diabetes & Metabolism Physician compares to other specialties among Arizona providers
MIPS score not measured
CMS assigned a neutral 75/100 threshold
CMS did not publish any Quality, Cost, Promoting Interoperability, or Improvement Activities category score for this clinician. This administrative threshold is not comparable with the national average of clinicians whose MIPS score was measured.
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1447231147 |
|---|---|
| Specialty | Endocrinology, Diabetes & Metabolism Physician |
| Credentials | M.D. |
| Gender | Female |
| NPI Issued | 11/09/2005 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
75
Final Score
CMS neutral threshold · not measured
Reporting: Group practice
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Seema Ahluwalia, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$3.3K
Largest payer
BETA BIONICS, INC.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Brand-heavy
Seema Ahluwalia, M.D. - brand share 51.0%
Endocrinology, Diabetes & Metabolism Physician average
51% brand-name claims vs 39% generic, on 8,215 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
8,215
Total Claims
$3.8M
Total Drug Cost
1,029
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 20,417.8
- Total Day Supply
- 607,189
- Brand vs Generic
- 51% brand / 39% generic
- Brand Drug Cost
- $3.5M
- Generic Drug Cost
- $70K
Patient Demographics
- Average Patient Age
- 69.0 years
- Avg HCC Risk Score
- 1.78
- Gender Split
- 65% female / 35% male
- Age Distribution
- <65: 213, 65-74: 502, 75-84: 273, 85+: 41
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Seema Ahluwalia, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2024
- Levothyroxine Sodium
Levothyroxine Sodium
1,168 claims
- Metformin Hcl 437
Metformin Hcl
437 claims
- Jardiance 399
Jardiance
399 claims
- Glimepiride 395
Glimepiride
395 claims
- Ozempic 325
Ozempic
325 claims
- Lantus Solostar 315
Lantus Solostar
315 claims
- Nano 2nd Gen Pen N… 304
Nano 2nd Gen Pen Needle
304 claims
- Atorvastatin Calcium 245
Atorvastatin Calcium
245 claims
| Drug | Claims |
|---|---|
| Levothyroxine Sodium | 1,168 |
| Metformin Hcl | 437 |
| Jardiance Empagliflozin | 399 |
| Glimepiride | 395 |
| Ozempic Semaglutide | 325 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 315 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 304 |
| Atorvastatin Calcium | 245 |
| Trulicity Dulaglutide | 227 |
| Methimazole | 180 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
More Endocrinology, Diabetes & Metabolism Physician in AZ →
All providers in Arizona →
Compare specialties →
Endocrinology, Diabetes & Metabolism Physician Overview
How Seema Ahluwalia, M.D. fits within the Endocrinology, Diabetes & Metabolism Physician landscape nationally.
8,078
Endocrinology, Diabetes & Metabolism Physician Providers in US
54
States with Endocrinology, Diabetes & Metabolism Physician
2,739
Avg Claims per Provider
Seema Ahluwalia, M.D.'s 8,215 claims are above the specialty average of 2,739.
Nationwide Endocrinology, Diabetes & Metabolism Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Ahluwalia, both outside Arizona so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (75 here).
Same NPPES enumeration year (2005)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Endocrinology, Diabetes & Metabolism Physician Providers in Arizona
Other clinicians with the same primary specialty enrolled in Arizona, drawn from the same CMS NPPES roster as Ahluwalia.
One of 120 Endocrinology, Diabetes & Metabolism Physician providers enrolled in Arizona, 5 are shown here.
Dr. Rtika Abraham
MD
Phoenix, AZ
Dr. Dima Abu Afifeh
MD
Tucson, AZ
Dr. Rashi Agarwal
M.D.
Peoria, AZ
Dr. Adnan Ajmal
MD
Phoenix, AZ
Dr. Osamah Al Ali
MD
Scottsdale, AZ
Compare Endocrinology, Diabetes & Metabolism Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Seema Ahluwalia, M.D.'s specialty? ▼
Seema Ahluwalia, M.D. specializes in Endocrinology, Diabetes & Metabolism Physician and practices in Chandler, Arizona. Credentials: M.D..
How much does Seema Ahluwalia, M.D. prescribe under Medicare Part D? ▼
In 2024, Seema Ahluwalia, M.D. wrote 8,215 Medicare Part D claims totaling $3.8M in drug costs for 1,029 beneficiaries.
What is Seema Ahluwalia, M.D.'s Medicare quality score? ▼
Seema Ahluwalia, M.D. has a CMS MIPS Final Score of 75/100. CMS published no Quality, Promoting Interoperability, Improvement Activity or Cost score for this clinician, so the final score is the neutral performance threshold CMS assigns rather than a measured result. The average MIPS Final Score across the 454,083 clinicians with at least one published category score is 83.5; clinicians whose score CMS assigned without scoring any category are excluded from that average. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Seema Ahluwalia, M.D. located? ▼
Seema Ahluwalia, M.D. is located at 2971 W ELLIOT RD, Chandler, AZ, 85224. Phone: (480) 733-5483.
What is Seema Ahluwalia, M.D.'s NPI number? ▼
Seema Ahluwalia, M.D.'s National Provider Identifier (NPI) is 1447231147, issued on 11/09/2005.
Does Seema Ahluwalia, M.D. prescribe more brand-name or generic drugs? ▼
Seema Ahluwalia, M.D.'s prescribing is 51% brand-name and 39% generic drugs by claim count, with $3.5M in brand drug costs.
How many Endocrinology, Diabetes & Metabolism Physician providers are there in the US? ▼
There are 8,078 Endocrinology, Diabetes & Metabolism Physician providers across 54 states in the US. The average Endocrinology, Diabetes & Metabolism Physician provider writes 2,739 Medicare Part D claims per year.
What drugs does Seema Ahluwalia, M.D. prescribe most often? ▼
Based on 2024 Medicare Part D data, Seema Ahluwalia, M.D.'s most frequently prescribed drugs include Levothyroxine Sodium, Metformin Hcl, Jardiance. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Seema Ahluwalia, M.D. accept Medicare? ▼
Seema Ahluwalia, M.D. appears in CMS Medicare data with 8,215 Part D claims and 1,029 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Seema Ahluwalia, M.D.'s credentials? ▼
Seema Ahluwalia, M.D.'s NPI is 1447231147 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.